Spaulding Clinical and Medidata Solutions Partner to Offer Clinical Data Management Integration

FOR IMMEDIATE RELEASE

Spaulding Clinical and Medidata Solutions Partner toOffer Clinical Data Management Integration
Offers Automatic Transfers of Spaulding ClinicalPhase I Data into Medidata Rave EDC/CDM System

NEW YORK, N.Y. and WEST BEND, WI. – June 10, 2010 – Leading SaaS-based clinical technology solutions provider Medidata Solutions (NASDAQ: MDSO), and leading-edge Phase I and Cardiac Core Lab provider Spaulding Clinical Research today announced the availability of a data integration between Spaulding Clinical?s Phase I unit and the Medidata Rave® system for electronic data capture, management and reporting for all phases of clinical trials. Leveraging the Medidata Rave Web Services API (application programming interface), the solution enables data collected in Spaulding?s Phase I unit, including clinical data, laboratory data and data collected via electronic monitoring devices, to be automatically transferred into Medidata Rave.

Sponsors of clinical research using both Medidata Rave for electronic data capture (EDC) and clinical data management (CDM) and Spaulding Clinical?s Phase I unit benefit from automatic, real-time data transfers into Rave, eliminating the need to reconcile mismatched data that has been entered into multiple systems and providing up-to-the-minute views of trial progress and results.

?In working with our joint customers, it has become quite evident to us that an enormous value-add would be to provide automatic data transfers of comprehensive Phase I data into Medidata Rave, so that sponsors can view, manage and report on their data in the platform they have already chosen for EDC/CDM: Medidata Rave,? said Brock Heinz, Systems Integration Engineer at Spaulding Clinical. ?We are excited to partner with Medidata Solutions to offer customers the ability to streamline Phase I trials by using their chosen platform in Phase I as well, so that they can manage and report on all their trials with the same optimized business processes.?

?We are excited to offer customers this innovative integration, which leverages industry standards to expedite data sharing across clinical technologies,? said Anne Zielinski, vice president of Alliances, Medidata Solutions. ?Spaulding Clinical has an innovative and technologically savvy approach to conducting Phase I trials, and our joint integration goes a long way to help customers realize the value of using market-leading technologies in Phase I trials.?

The Medidata?Spaulding Clinical integration also marks Spaulding Clinical?s membership into the Medidata Technology Partner Program, which recognizes technology providers, contract research organizations and other organizations that have clinical solutions integrated with Medidata products. Since its introduction in June of 2009, the Medidata Technology Partner Program has grown to include nine organizations that offer solutions supporting data sharing with Medidata products in order to streamline and enhance the end-to-end e-Clinical process.

About Spaulding Clinical
Spaulding Clinical (www.spauldingclinical.com) is a Phase I Clinical Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services including TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, food effect studies, PK/PD characterization, and data collection and management. Spaulding Clinical also offers a full suite of Electrocardiography Core Lab and over-reading services with state of-the-art technology and cardiac expertise.

About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager®), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor®), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

Spaulding Clinical Contact:
Amanda Baltz Sr. Director, Business Operations and Development
+1.262.306.3324
amanda.baltz@spauldingclinical.com

Medidata Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com